Bär & Karrer advises THERAMetrics and Relief Therapeutics on link-up

On 21 December 2015, THERAMetrics and RELIEF THERAPEUTICS announced that they had signed a binding agreement to combine their businesses by way of an exchange of RELIEF’s shares for new THERAMetric shares. THERAMetrics is a biotechnology company listed on the main segment of the SIX Swiss Exchange and RELIEF is a privately held biotech-start-up based in Geneva.

Bär & Karrer is acting as lead transaction counsel. The team includes Thomas Reutter, Rolf Watter, Daniel Heiniger and Daniel Küpfer (all M&A), Susanne Schreiber (Tax) and Jonas Bornhauser (IP).